Norma Sebestyen has extensive experience over a 28 year career with Merck in Sales, Marketing, Strategic Planning, Corporate Affairs, Health Education, Government Relations, Operations and Policy and Patient Access. Most recently she was involved in developing and management of key partnerships for Merck in Health Information Technology, and Health Data Science along with Life Sciences Accelerators/Research collaborations. She is also the past Vice – Chair of Canada’s Research Based Pharmaceutical Companies (IMC) Western Committee.
Norma has a Bachelor of Commerce Degree in Finance and Marketing along with a MBA in International Business. She also completed diplomas at Duke University in Biotechnology and McGill University in Pharmacoeconomics. In addition, over the period of her career at Merck she was involved in extensive training and international senior leadership programs. She has published articles in Healthcare Management Forum on healthcare partnerships and collaborations.
Norma has been a Board member of Providence Research Institute since 2010. She previously was on the Board of UBC Sauder School of Business, Executive MBA Program. She is a member of the 2018 Federal Health Economic Table – Digital Health Taskforce that made recommendations on Digital Health Strategies to the Federal Ministry of Innovation and Health. She has also recently been appointed to the Canadian Glycomics Network (GlycoNet) Board. She currently is an Advisor to companies in health information technology.